Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2003

View Archived Issues

Phase II findings for onercept in psoriasis and psoriatic arthritis

Peregrine presents antibodies targeting phosphatidylserine

Applied Molecular Evolution to optimize Lilly protein therapeutic candidates

Gilead and Bukwang clevudine licensing agreement terminated

Curis collaboration focusing on Hedgehog signaling pathway

Lorus selects lead antisense compound to target thioredoxin

Inflazyme completes acquisition of GlycoDesign

Y-700 found to inhibit uric acid formation in healthy adult volunteers

SCV-07 stimulates Th1 immune response in TB animal model

Analgesic effects reported for gabapentin in chronic radiculopathy

SMP-114 has good safety profile in healthy volunteers

Durable clinical response found for alefacept plus methotrexate in severe rheumatoid arthritis

Clinical benefits of a human monoclonal antibody against IL-15 in active rheumatoid arthritis

Three series of CCR3 antagonists with utility in asthma therapy claimed by Roche

New GABA-C receptor antagonists and their use as cognition-enhancing agents

Antitumor epothilones identified by Kosan scientists

Pharmacia (Pfizer) team identifies novel pyrazine-based CRF1 antagonists

Apoptosis inducers prepared and tested at the Burnham Institute

Scientists at Fujisawa and Daiso present novel apo B secretion inhibitors

New factor Xa inhibitors and their use covered by Warner-Lambert patent

Idec and Biogen to merge

Enbrel recommended by FDA panel to treat ankylosing spondylitis

Savient chosen as new corporate name for Bio-Technology General

Pilot study of Probuphine initiated for treatment of opiate addiction

MLN-2201 enters phase I testing

CPMP hands down positive opinion for survival claim for MabCampath

European Commission grants marketing authorization for Aldurazyme in Europe

FDA clears IND for dextofisopam for IBS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...